737 related articles for article (PubMed ID: 27311178)
1. [Rheumatoid arthritis and cytokines].
Kaneko S; Kondo Y; Yokosawa M; Sumida T
Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
[TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanisms of bone destruction in rheumatoid arthritis].
Nanki T
Clin Calcium; 2007 Apr; 17(4):510-6. PubMed ID: 17404479
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of bone destruction and the contribution of T lymphocytes].
Komatsu N
Nihon Rinsho; 2016 Jun; 74(6):907-12. PubMed ID: 27311177
[TBL] [Abstract][Full Text] [Related]
4. Synovial IL-21/TNF-producing CD4
Lebre MC; Vieira PL; Tang MW; Aarrass S; Helder B; Newsom-Davis T; Tak PP; Screaton GR
J Leukoc Biol; 2017 Mar; 101(3):775-783. PubMed ID: 27733582
[TBL] [Abstract][Full Text] [Related]
5. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
[TBL] [Abstract][Full Text] [Related]
6. [Bone and cartilage destruction in rheumatoid arthritis].
Komatsu N; Takayanagi H
Clin Calcium; 2012 Feb; 22(2):179-85. PubMed ID: 22298070
[TBL] [Abstract][Full Text] [Related]
7. A pro-inflammatory role for A20 and ABIN family proteins in human fibroblast-like synoviocytes in rheumatoid arthritis.
Igarashi H; Yahagi A; Saika T; Hashimoto J; Tomita T; Yoshikawa H; Ishihara K
Immunol Lett; 2012 Jan; 141(2):246-53. PubMed ID: 22093807
[TBL] [Abstract][Full Text] [Related]
8. IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation.
Corvaisier M; Delneste Y; Jeanvoine H; Preisser L; Blanchard S; Garo E; Hoppe E; Barré B; Audran M; Bouvard B; Saint-André JP; Jeannin P
PLoS Biol; 2012; 10(9):e1001395. PubMed ID: 23055831
[TBL] [Abstract][Full Text] [Related]
9. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
10. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Di Padova FE; Boots AM; Gram H; Joosten LA; van den Berg WB
Am J Pathol; 2005 Jul; 167(1):141-9. PubMed ID: 15972960
[TBL] [Abstract][Full Text] [Related]
11. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
Azizi G; Jadidi-Niaragh F; Mirshafiey A
Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
[TBL] [Abstract][Full Text] [Related]
12. IL-32, a proinflammatory cytokine in rheumatoid arthritis.
Joosten LA; Netea MG; Kim SH; Yoon DY; Oppers-Walgreen B; Radstake TR; Barrera P; van de Loo FA; Dinarello CA; van den Berg WB
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3298-303. PubMed ID: 16492735
[TBL] [Abstract][Full Text] [Related]
13. IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration.
Tanida S; Yoshitomi H; Ishikawa M; Kasahara T; Murata K; Shibuya H; Ito H; Nakamura T
Cytokine; 2011 Aug; 55(2):237-44. PubMed ID: 21592822
[TBL] [Abstract][Full Text] [Related]
14. Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts.
Yamamoto A; Fukuda A; Seto H; Miyazaki T; Kadono Y; Sawada Y; Nakamura I; Katagiri H; Asano T; Tanaka Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2003 Sep; 48(9):2682-92. PubMed ID: 13130489
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune arthritis: the interface between the immune system and joints.
Komatsu N; Takayanagi H
Adv Immunol; 2012; 115():45-71. PubMed ID: 22608255
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
[TBL] [Abstract][Full Text] [Related]
17. Temporal expression patterns of distinct cytokines and M1/M2 macrophage polarization regulate rheumatoid arthritis progression.
Kung CC; Dai SP; Chiang H; Huang HS; Sun WH
Mol Biol Rep; 2020 May; 47(5):3423-3437. PubMed ID: 32277445
[TBL] [Abstract][Full Text] [Related]
18. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
[TBL] [Abstract][Full Text] [Related]
19. Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis.
Park YH; Kim HJ; Lee K; Choi Y; Heo TH
Biochem Biophys Res Commun; 2020 Feb; 522(4):1030-1036. PubMed ID: 31818460
[TBL] [Abstract][Full Text] [Related]
20. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
